|
| |
| | | 66340 | | 09.11.2017 | | Teva Pharma AG | | | | | | | | | | | | | 03.04.50. | | | | 03.04.50. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Cinqaero 100 mg/10 mL | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Reslizumabum 100mg / 10ml) | R03DX08 | | | 02 | Cinqaero 25 mg/2,5 mL | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Reslizumabum 25mg / 2.5ml) | R03DX08 | |
|
|
|
